Trimble Inc. - Common Stock (TRMB)
Healthcare › Measuring & Controlling Devices, NEC
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 143% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 5.3% — below-average profitability
Trimble Inc. - Common Stock (TRMB) is a Healthcare company operating in Measuring & Controlling Devices, NEC, listed on the NASDAQ , with a market capitalisation of $15.5 billion . Key value metrics: P/E ratio 50.2, P/B ratio 2.65, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Trimble Inc. - Common Stock — Fundamental Analysis Summary
Trimble Inc. - Common Stock (TRMB) is currently trading 143% above its Graham Number of $27.19, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 50.2x.
On financial health, TRMB shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 5.3% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.25.
StockPik's composite Value Score for TRMB is 66/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TRMB reports a high gross margin of 67.4% (sector average: 33.5%) and a solid operating margin of 14.1%.
TRMB shows revenue declining at 3% year-over-year, with earnings declining at 72%.